219 related articles for article (PubMed ID: 25268459)
1. Covalent small molecule inhibitors of Ca(2+)-bound S100B.
Cavalier MC; Pierce AD; Wilder PT; Alasady MJ; Hartman KG; Neau DB; Foley TL; Jadhav A; Maloney DJ; Simeonov A; Toth EA; Weber DJ
Biochemistry; 2014 Oct; 53(42):6628-40. PubMed ID: 25268459
[TBL] [Abstract][Full Text] [Related]
2. Small Molecule Inhibitors of Ca(2+)-S100B Reveal Two Protein Conformations.
Cavalier MC; Ansari MI; Pierce AD; Wilder PT; McKnight LE; Raman EP; Neau DB; Bezawada P; Alasady MJ; Charpentier TH; Varney KM; Toth EA; MacKerell AD; Coop A; Weber DJ
J Med Chem; 2016 Jan; 59(2):592-608. PubMed ID: 26727270
[TBL] [Abstract][Full Text] [Related]
3. Small molecules bound to unique sites in the target protein binding cleft of calcium-bound S100B as characterized by nuclear magnetic resonance and X-ray crystallography.
Charpentier TH; Wilder PT; Liriano MA; Varney KM; Zhong S; Coop A; Pozharski E; MacKerell AD; Toth EA; Weber DJ
Biochemistry; 2009 Jul; 48(26):6202-12. PubMed ID: 19469484
[TBL] [Abstract][Full Text] [Related]
4. The effects of CapZ peptide (TRTK-12) binding to S100B-Ca2+ as examined by NMR and X-ray crystallography.
Charpentier TH; Thompson LE; Liriano MA; Varney KM; Wilder PT; Pozharski E; Toth EA; Weber DJ
J Mol Biol; 2010 Mar; 396(5):1227-43. PubMed ID: 20053360
[TBL] [Abstract][Full Text] [Related]
5. Specificity of Molecular Fragments Binding to S100B versus S100A1 as Identified by NMR and Site Identification by Ligand Competitive Saturation (SILCS).
Young BD; Yu W; Rodríguez DJV; Varney KM; MacKerell AD; Weber DJ
Molecules; 2021 Jan; 26(2):. PubMed ID: 33450915
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interaction.
Markowitz J; Chen I; Gitti R; Baldisseri DM; Pan Y; Udan R; Carrier F; MacKerell AD; Weber DJ
J Med Chem; 2004 Oct; 47(21):5085-93. PubMed ID: 15456252
[TBL] [Abstract][Full Text] [Related]
7. The calcium-binding protein S100B down-regulates p53 and apoptosis in malignant melanoma.
Lin J; Yang Q; Wilder PT; Carrier F; Weber DJ
J Biol Chem; 2010 Aug; 285(35):27487-27498. PubMed ID: 20587415
[TBL] [Abstract][Full Text] [Related]
8. Novel protein-inhibitor interactions in site 3 of Ca(2+)-bound S100B as discovered by X-ray crystallography.
Cavalier MC; Melville Z; Aligholizadeh E; Raman EP; Yu W; Fang L; Alasady M; Pierce AD; Wilder PT; MacKerell AD; Weber DJ
Acta Crystallogr D Struct Biol; 2016 Jun; 72(Pt 6):753-60. PubMed ID: 27303795
[TBL] [Abstract][Full Text] [Related]
9. In vitro screening and structural characterization of inhibitors of the S100B-p53 interaction.
Wilder PT; Charpentier TH; Liriano MA; Gianni K; Varney KM; Pozharski E; Coop A; Toth EA; Mackerell AD; Weber DJ
Int J High Throughput Screen; 2010 Jul; 2010(1):109-126. PubMed ID: 21132089
[TBL] [Abstract][Full Text] [Related]
10. A novel mode of target recognition suggested by the 2.0 A structure of holo S100B from bovine brain.
Matsumura H; Shiba T; Inoue T; Harada S; Kai Y
Structure; 1998 Feb; 6(2):233-41. PubMed ID: 9519413
[TBL] [Abstract][Full Text] [Related]
11. Divalent metal ion complexes of S100B in the absence and presence of pentamidine.
Charpentier TH; Wilder PT; Liriano MA; Varney KM; Pozharski E; MacKerell AD; Coop A; Toth EA; Weber DJ
J Mol Biol; 2008 Sep; 382(1):56-73. PubMed ID: 18602402
[TBL] [Abstract][Full Text] [Related]
12. Structural Basis of Ribosomal S6 Kinase 1 (RSK1) Inhibition by S100B Protein: MODULATION OF THE EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK) SIGNALING CASCADE IN A CALCIUM-DEPENDENT WAY.
Gógl G; Alexa A; Kiss B; Katona G; Kovács M; Bodor A; Reményi A; Nyitray L
J Biol Chem; 2016 Jan; 291(1):11-27. PubMed ID: 26527685
[TBL] [Abstract][Full Text] [Related]
13. X-ray crystal structure of human calcium-bound S100A1.
Melville Z; Aligholizadeh E; McKnight LE; Weber DJ; Pozharski E; Weber DJ
Acta Crystallogr F Struct Biol Commun; 2017 Apr; 73(Pt 4):215-221. PubMed ID: 28368280
[TBL] [Abstract][Full Text] [Related]
14. The evolution of S100B inhibitors for the treatment of malignant melanoma.
Hartman KG; McKnight LE; Liriano MA; Weber DJ
Future Med Chem; 2013 Jan; 5(1):97-109. PubMed ID: 23256816
[TBL] [Abstract][Full Text] [Related]
15. Target binding to S100B reduces dynamic properties and increases Ca(2+)-binding affinity for wild type and EF-hand mutant proteins.
Liriano MA; Varney KM; Wright NT; Hoffman CL; Toth EA; Ishima R; Weber DJ
J Mol Biol; 2012 Oct; 423(3):365-85. PubMed ID: 22824086
[TBL] [Abstract][Full Text] [Related]
16. Calcium-binding properties of wild-type and EF-hand mutants of S100B in the presence and absence of a peptide derived from the C-terminal negative regulatory domain of p53.
Markowitz J; Rustandi RR; Varney KM; Wilder PT; Udan R; Wu SL; Horrocks WD; Weber DJ
Biochemistry; 2005 May; 44(19):7305-14. PubMed ID: 15882069
[TBL] [Abstract][Full Text] [Related]
17. Monitoring Interactions Between S100B and the Dopamine D2 Receptor Using NMR Spectroscopy.
Wang Y; Tadayon R; Shaw GS
Methods Mol Biol; 2019; 1929():311-324. PubMed ID: 30710282
[TBL] [Abstract][Full Text] [Related]
18. Solution structure of zinc- and calcium-bound rat S100B as determined by nuclear magnetic resonance spectroscopy.
Wilder PT; Varney KM; Weiss MB; Gitti RK; Weber DJ
Biochemistry; 2005 Apr; 44(15):5690-702. PubMed ID: 15823027
[TBL] [Abstract][Full Text] [Related]
19. Blocking the interface region amongst S100A6 and RAGE V domain via S100B protein.
Sung HY; Dowarha D; Chou RH; Yu C
Biochem Biophys Res Commun; 2020 Dec; 533(3):332-337. PubMed ID: 32958253
[TBL] [Abstract][Full Text] [Related]
20. Deciphering S100B Allosteric Signaling: The Role of a Peptide Target, TRTK-12, as an Ensemble Modulator.
Samanta R; Zhuang X; Varney KM; Weber DJ; Matysiak S
J Chem Inf Model; 2024 Apr; 64(8):3477-3487. PubMed ID: 38605537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
